JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Biochemical Reagent
Anti-infection

Anti-infection

BA2250 Clesrovimab

Summary: Clesrovimab (MK1654) is a fully human anti-fusion (RSVF) glycoprotein monoclonal antibody.
BA2251 Enzaplatovir

Summary: Enzaplatovir (BTA-C585) is an orally effective fusion inhibitor.
BA2252 BMS-433771

Summary: BMS-433771 is a potent respiratory syncytial virus (RSV) inhibitor with oral activity.
BA2254 RSV-IN-1

Summary: RSV-IN-1 is an inhibitor of human respiratory syncytial virus.
BA2256 Paquinimod

Summary: Paquinimod (ABR215757) is a specific inhibitor with oral activity.

≥50.3 mg/mL
BA2259 Ensitrelvir

Summary: Ensitrelvir (S-217622) is the first to be orally active.
BA2263 Merafloxacin

Summary: Merafloxacin (CI-934), a fluoroquinolone antimicrobial agent, is a selective programmed-1 ribosome translocation inhibitor of beta viruses.
BA2265 PF-00835231

Summary: PF-00835231 is an inhibitor of a major viral protease.
BA2267 Ibuzatrelvir

Summary: Ibuzatrelvir (PF-07817883), second-generation oral bioavailability, is a SARS-CoV-2 major protease (and) inhibitor with improved metabolic stability.
BA2269 GS-621763

Summary: GS-621763 is an orally effective precursor to GS-441524.